Tacrolimus

Form: Capsule

Strength: IR:0.5 mg, 1 mg , 5 mg; ER: 0.5 mg, 1 mg, 3 mg, 5 mg

Reference Brands: US: Prograf IR, Astagraf XL; EU: Prograf,Advagraf(PR)

Category: Oncology Cancer Care

Tacrolimus Capsules are essential immunosuppressants widely used in organ transplant patients to prevent rejection. Available in both immediate-release (Prograf) and extended-release forms (Astagraf XL, Envarsus), these capsules are offered in strengths of 0.5 mg, 1 mg, 3 mg, 4 mg, and 5 mg across the U.S. and EU markets. Tacrolimus effectively inhibits T-lymphocyte activation, making it a vital part of post-transplant care. With multiple dosing options, it supports individualized therapy. Suitable for B2B pharmaceutical distribution, Tacrolimus capsules are available in branded and generic forms, ensuring broad accessibility and cost-effective solutions for hospitals, clinics, and healthcare providers in Europe and the U.S.